DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Funds / Ascent Biomedical Ventures II NY, L.P.
Ascent Biomedical Ventures II NY, L.P.
Amounts, each with its basis
- Vintage
- unknownno dated first sale or first report yet
- Target
- unknownnot announced
- First close
- unknownnever inferred from a Form D
- Final close
- unknownonly from an announcement or an LP disclosure
- Announced size
- unknown
- Form D offering
- unknownwhat may be sold, not what was raised
- Form D sold
- unknown
- First sale
- unknown
- Reported GAV
- $17.4Mon the Form ADV filed Mar 30, 2022; the fund's assets, never its size or dry powder
- Owners (ADV)
- 2
- Reported on ADV
- Mar 30, 2012 to Mar 30, 2022
Fundraising evidence
Unknown
no Form D or close on record (fr-1)
A Form D offering is permission to sell, not a fund in market; an amount sold is never a close; an evergreen offering amended every year is not a raise.
Lifecycle
Unknown
no vintage and no recent Form D
first sale: n/avintage year: n/aadv gav as of: 2022-03-30vintage basis: n/aform d sold usd: n/aform d offering usd: n/aform d latest filed at: n/a
The fund's own reporting through time
11 Form ADV filings
| Filed | Type | Gross asset value | Owners | Min. investment | Adviser-owned | Audit | |
|---|---|---|---|---|---|---|---|
| Mar 30, 2012 | Venture Capital Fund | $3.8M | 2 | $250,000 | 1% | yes | |
| Apr 1, 2013 | Venture Capital Fund | $3.8M | 2 | $250,000 | 1% | yes | |
| Mar 31, 2014 | Venture Capital Fund | $7.4M | 2 | $250,000 | 1% | yes | |
| Mar 31, 2015 | Venture Capital Fund | $8.9M | 2 | $250,000 | 1% | yes | |
| Mar 30, 2016 | Venture Capital Fund | $8.9M | 2 | $250,000 | 1% | yes | |
| Mar 31, 2017 | Venture Capital Fund | $8.9M | 2 | $250,000 | 1% | yes | |
| Apr 13, 2018 | Venture Capital Fund | $17.6M | 2 | $250,000 | 1% | yes | |
| Mar 26, 2019 | Venture Capital Fund | $17.6M | 2 | $250,000 | 1% | yes | |
| May 27, 2020 | Venture Capital Fund | $17.6M | 2 | $250,000 | 1% | yes | |
| Mar 31, 2021 | Venture Capital Fund | $17.4M | 2 | $250,000 | 1% | yes | |
| Mar 30, 2022 | Venture Capital Fund | $17.4M | 2 | $250,000 | 1% | yes |
Principals and agents
0 principals on Form D, 0 placement agents
No Form D related person on record.
Limited partners and their reported performance
1 public LP report
| LP | Vintage (LP’s) | Committed | Paid in | Distributed | Remaining value | Net IRR | Multiple | As of |
|---|---|---|---|---|---|---|---|---|
| New York State Common Retirement Fund osc.ny.gov | 2008 | $25.0M | $25.0M | $0 | $7.1M | not meaningful yet | 0.3x | Mar 31, 2025 |
Each row is the LP’s own number: its cash flows and its valuation policy as of its reporting date, not the fund’s. Net IRR is printed only when the LP prints one. The vintage is the LP’s definition (CalPERS: year of its first cash flow; WSIB: year of its initial investment).
Investments attributed to this vehicle
0
No investment attributed to this vehicle. The firm’s investments sit on the firm; a fund gets one only when a source names the vehicle.
Timeline
2 events
- Mar 31, 2025NYSCRF reports Ascent Biomedical Ventures NY II, LP: $25,000,000 committed, vintage 2008LP commitment disclosed Fact Public pension and endowment private-markets disclosures (CalPERS, CalSTRS, WSIB, NYSCRF, Texas TRS, UTIMCO ...)
- Mar 30, 2012Ascent Biomedical Ventures II NY, L.P. first reported on Form ADV by ABV, LLC (Venture Capital Fund), GAV $3,846,966Fund first reported on Form ADV Fact SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Evidence
0 observations